Jefferies downgraded Imperial Brands PLC from 'buy' to 'hold' and cut its price target due to expected German cigarette tax increases from 2027 to 2030. These hikes could raise cigarette prices significantly, leading to reduced legal sales and increased illicit trade, especially since Germany accounts for 15% of Imperial's operating profit. Jefferies lowered its forecasts for tobacco volume decline, sales growth, and profit growth, warning that higher taxes and cheaper illicit alternatives will pressure Imperial's future earnings. The company’s 2026 financial results and 2027 guidance, due in November, may reflect these challenges, with current market expectations seen as overly optimistic.
Imperial Brands downgrades amid German cigarette price concerns offer context for consumer staples investors. For readers following Consumer Staples, here is Pluang's market snapshot as of Oct 19, 2026 17:11 WIB: Of 63 priced US stocks in the sector, 5 rose and 43 fell today. Notable movers include Conagra Brands Inc (CAG) at USD 14.36, down 0.76%, McCormick & Company (MKC) at USD 46.00, down 0.76%, and Altria Group Inc (MO) at USD 74.55, down 0.75%. Typical hold times on Pluang range from 68 to 156 days for these stocks.
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
